news
Best wishes for the New Year 2023
Almost 58% of men suffer from chronic prostatitis
2022: new opportunities for Russian pharmaceutical companies
Vaccine as an investment: how the state should protect the population from infectious diseases
Igor Borisenko: "A turbulent period has come, but pharmaceutical companies are adapting quickly"
Doing the best to fight pneumococcus: the experience of organization of Russian production of innovative vaccines for National vaccination schedule
Polyoxidonium® drug and Grippol® Quadrivalent vaccine are included in the guidelines for ARVIs prevention
“Thinking and reflection of the present and future of patients recovered from COVID-19”: how to treat post-COVID syndrome?”
Mikhail Grubman at the “Right to Health” congress: We all share in the common cause...
